Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer - Concepedia

Concepedia

Publication | Open Access

Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer

DOI Full Paper Access

177

Citations

49

References

2015

Year

Bi-Yun Wang, Jian Zhang, Jia-Lei Wang, Si Sun, Zhong-Hua Wang, Lei-Ping Wang, Qun-Ling Zhang, Fang-Fang Lv, En-Ying Cao, Zhi-Min Shao,

Journal of Experimental & Clinical Cancer Research

Abstract

Clinicaltrials.gov identifier: NCT01069081 .

References

	Year	Citations
Microenvironmental pH Is a Key Factor for Exosome Traffic in Tumor Cells Isabella Parolini, Cristina Federici, Carla Raggi, Journal of Biological Chemistry	2009	1.5K
Superior Survival With Capecitabine Plus Docetaxel Combination Therapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer: Phase III Trial Results Joyce O’Shaughnessy, David Miles, Svetislava J. Vukelja, Journal of Clinical Oncology	2002	1.1K
High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients Mariantonia Logozzi, Angelo De Milito, Luana Lugini, PLoS ONE	2009	959
Glutathione-Associated Enzymes In Anticancer Drug Resistance Kenneth D. Tew Cancer Research Chemoprevention StrategyBiochemistryOncogenic AgentMedicineGlutathione Pathways	2016	858
Bicarbonate Increases Tumor pH and Inhibits Spontaneous Metastases Ian Robey, Brenda Baggett, Nathaniel D. Kirkpatrick, Cancer Research	2009	643
Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes Arianna Calcinotto, Paola Filipazzi, Matteo Grioni, Cancer Research ImmunologyImmune RegulationImmunoeditingImmunologic MechanismImmunotherapeutics	2012	597
Effect of Proton Pump Inhibitor Pretreatment on Resistance of Solid Tumors to Cytotoxic Drugs Francesca Luciani, Massimo Spada, Angelo De Milito, JNCI Journal of the National Cancer Institute	2004	434
Gemcitabine Plus Paclitaxel Versus Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer and Prior Anthracycline Treatment Kathy S. Albain, Shona Nag, G. Calderillo-Ruiz, Journal of Clinical Oncology	2008	418
Design Issues of Randomized Phase II Trials and a Proposal for Phase II Screening Trials Edward L. Korn, Boris Freidlin, Sally Hunsberger, Journal of Clinical Oncology	2005	395
Tumor acidity, ion trapping and chemotherapeutics Brent P. Mahoney, Natarajan Raghunand, Brenda Baggett, Biochemical Pharmacology MedicineTumor AcidityCancer BiologyRadiation OncologyCancer Research	2003	346

Page 1